比利時安特衛普, 2026年3月23日 - (亞太商訊 via SeaPRwire.com) - 這是該公司第11次獲評為「領導者」。OMP 認為,此項殊榮彰顯了其持續提供創新解決方案(如 UnisonIQ 和 Unison 決策導向規劃)的實力。這反映了市場正朝向 AI 驅動的供應鏈規劃轉變,以及市場對能即時整合策略、執行與智慧的平台的日益增長的需求。為最複雜的供應鏈需求推動智慧規劃OMP 獲得阿斯特捷利康、巴斯夫、強生及寶潔等《財星》500 強企業的信賴,並持續透過其經實證的端到端平台 Unison Planning™,推動供應鏈規劃的進展。該平台具備開放、雲原生及 AI 驅動的特性,專為滿足流程型與離散型全球供應鏈的演變需求而打造,涵蓋化學品、消費品、生命科學、紙張與包裝、輪胎與建築材料,以及金屬等產業。Unison Planning™ 整合了 OMP 的 AI 協調器 UnisonIQ,將 AI 代理、助理與引擎統一於一個強大的框架之中。UnisonIQ 專為供應鏈規劃的「代理時代」而設計,將持續性智慧嵌入整個平台,為企業奠定基礎,使其能基於深厚的產業專業知識,進行主動且自主的決策。「代理式 AI 正在從根本上重塑供應鏈的運作與競爭模式,」OMP 執行長 Paul Vanvuchelen 表示。「擁抱這項轉變的企業,將能將市場波動轉化為戰略優勢。」加速整個供應鏈的決策速度OMP 的 Unison 決策導向規劃(Unison Decision‑Centric Planning)透過整合人類專業知識、先進 AI、即時智慧及快速情境評估,提升供應鏈績效,從而推動企業整體的決策速度並改善決策品質。「憑藉全面的供應鏈智慧與 AI 驅動的預判能力,Unison 決策導向規劃能讓企業更早預見干擾因素、評估其影響,並以清晰且充滿信心的態度籌劃下一步行動,」OMP 首席商務與市場官 Philip Vervloesem 表示。關於 Gartner 魔力象限2026年3月發布的《2026年Gartner供應鏈規劃解決方案魔力象限:流程工業》報告,依據供應商的「執行能力」與「願景完整性」進行評估,協助全球企業在複雜且快速演變的市場中識別合適的合作夥伴。我們相信,這項認可與 OMP 在《2026 年 Gartner 流程工業供應鏈規劃解決方案關鍵能力報告》中的優異表現密不可分——該報告中,OMP 在所有應用場景中均名列前兩名。此外,OMP 在 Gartner Peer Insights™ 上持續獲得客戶的高度評價,反映出企業用戶的正面反饋。欲進一步了解 OMP 在 Gartner 魔力象限中的領導者地位以及供應鏈規劃的未來發展,請閱讀完整報告。於 Gartner 供應鏈研討會/博覽會™ 親臨 OMP 攤位OMP 將參與 2026 年 Gartner 供應鏈研討會/博覽會™,屆時客戶將分享關於智慧型、以決策為中心的供應鏈之實務見解:寶潔公司將在美國場次(Symposium/Xpo™ US)分享與 OMP 合作的重要經驗,重點闡述整合式規劃與端到端可視性如何帶來可量化的商業效益。阿斯特捷利康將在歐洲、中東及非洲場次(Symposium/Xpo™ EMEA)展示其邁向以決策為中心的自主規劃之旅,重點說明該公司如何透過轉型流程與能力以達成卓越表現。關於 OMPOMP 透過提供市場上最卓越的數位化供應鏈規劃解決方案,協助面臨複雜規劃挑戰的企業脫穎而出、成長並蓬勃發展。來自消費品、生命科學、化學、金屬、紙業、塑膠與包裝、輪胎及建築材料等廣泛產業的數百家客戶,皆因採用 OMP 獨有的 Unison Planning™ 而受益。Gartner,《供應鏈規劃解決方案魔力象限》,Pia Orup Lund、Joe Graham、Buse Aras、Jan Snoeckx、Eva Dawkins、Julia von Massow,2026年3月18日。Gartner,《供應鏈規劃解決方案關鍵能力:流程工業》,Julia von Massow、Eva Dawkins、Jan Snoeckx、Buse Aras、Joe Graham、Pia Orup Lund,2026年3月18日。Gartner 及 Magic Quadrant 均為 Gartner, Inc. 及其關聯公司的商標。Gartner 並不認可其出版物中所提及的任何公司、供應商、產品或服務,亦不建議技術使用者僅選擇評級最高或其他獲特殊標示的供應商。Gartner 出版物反映的是 Gartner 商業與技術洞察組織的觀點,不應被視為事實陳述。Gartner 對本出版物不作任何明示或暗示的保證,包括任何適銷性或適用於特定目的的保證。Gartner Peer Insights 的內容包含個別終端使用者基於自身經驗所提出的意見,不應被視為事實陳述,亦不代表 Gartner 或其關聯公司的觀點。Gartner 不對本內容中所述的任何供應商、產品或服務予以背書,亦不就本內容的準確性或完整性作出任何明示或暗示的保證,包括任何適銷性或特定用途適用性的保證。解決方案與產品諮詢聯絡 OMP媒體諮詢Kira Perdue (Carabiner)消息來源:OMP Copyright 2026 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com
Officers Fatally Shoot Man Who Drew Gun in Casino Parking Lot
(AsiaGameHub) - A man was fatally shot after brandishing a firearm when confronted by law enforcement. The incident occurred in the parking lot of WinStar Casino in Thackerville, Oklahoma. Authorities Report Victim Threatened Officers with a Firearm On March 19, the Chickasaw Lighthorse Police Department received information about an individual experiencing suicidal ideation on WinStar Casino grounds. According to the official report from the Oklahoma State Bureau of Investigation (OSBI), the person was identified as 41-year-old Kevin Odom. Officers were immediately sent to the location. They found the man around 1:45 pm in the casino parking lot. Police attempted to communicate with the reportedly suicidal individual, but he drew a weapon. An officer subsequently discharged their weapon, striking Odom. He sustained injuries and was pronounced dead at the scene. The OSBI report confirmed that no other individuals were injured during the incident. The investigation remains active and is being conducted jointly by the OSBI, Chickasaw Lighthorse Police Department, WinStar Casino, and the Office of the Chief Medical Examiner. The Love County Sheriff's Office released a statement confirming the shooting and assuring residents that public safety is not at risk. Chief Palmer of the Chickasaw Lighthorse Police has assured me that the public faces no continuing danger. All additional questions should be referred to the Chickasaw Lighthorse Police, who are spearheading the investigation alongside the OSBI. Sheriff Cumberledge Regrettably, Not an Isolated Casino-Related Shooting Incident Tragically, this is not the sole shooting incident to occur near a casino property in 2026. In the previous month, a deadly shooting occurred just outside Bally's Kansas City Casino, resulting in the death of an 18-year-old. The incident stemmed from an altercation involving several individuals that began inside the casino. Several days afterward, a mother who was in Las Vegas for a dance competition fatally shot her daughter before committing suicide. This article is provided by a third-party. AsiaGameHub (https://asiagamehub.com/) makes no warranties regarding its content. AsiaGameHub delivers targeted distribution for iGaming, Casino, and eSports, connecting 3,000+ premium Asian media outlets and 80,000+ specialized influencers across ASEAN.
Lexington County Man Charged with Illegal Gambling After Devices Discovered at His Residence
(AsiaGameHub) - Lexington County police and the South Carolina Law Enforcement Division have arrested 51-year-old W. L. H. Sr., whom they suspect ran an illegal gambling operation. The arrest took place on March 9, 2026, and the man was immediately charged with possession of an illegal gambling machine—described as “unlawful possession and operation of a slot, video, vending machine or gambling device and unlawful games and betting.” This final charge is significant because while police can technically bring unlawful betting charges, they rarely do so. The arrest happened a week after a search warrant was executed on March 2. 18 Gambling Machines Seized as Part of the Operation During the search, police found 18 gambling machines at the suspect’s home—specifically Pot O Gold devices. These machines can run a range of games of chance, including keno, blackjack, and casino-style poker. South Carolina has been fairly conservative in its gambling regulation, which has led to the rise of underground operations like the one run by H. Sr. In February, Senate Bill 444 attempted to introduce online sports betting regulation in the state, but it faced opposition from lawmakers. In-state sports betting is available at Harrah’s Cherokee Casino Resort in Cherokee, Harrah’s Cherokee Valley River in Murphy, and Catawba Two Kings Casino in Kings Mountain. This article is provided by a third-party. AsiaGameHub (https://asiagamehub.com/) makes no warranties regarding its content. AsiaGameHub delivers targeted distribution for iGaming, Casino, and eSports, connecting 3,000+ premium Asian media outlets and 80,000+ specialized influencers across ASEAN.
Kalshi Withdraws From Nevada as Fresh New Lawsuit Targets the Company’s Founders
(AsiaGameHub) - Kalshi has been compelled to leave a U.S. state for the first time, temporarily halting access to its sports markets in Nevada after a judge issued a temporary restraining order (TRO) against the company. Legal disputes over the platform’s contentious sports prediction markets are escalating, and a new lawsuit has targeted Kalshi’s co-founders personally. The Nevada Gaming Control Board (NGCB) announced the state issued the TRO on Friday. In a press release, Chairman Mike Dreitzer stated, “Kalshi has repeatedly claimed its operations are legal in all 50 states, which is clearly false.” “Prediction markets that enable unlicensed gambling are illegal in Nevada, and we have a statutory duty to protect the public. We want Nevada residents to wager safely with a licensed bookmaker.” The TRO remains in effect until April 3, when a hearing will be held. Kalshi’s departure from the state follows a judge’s denial of the company’s request for an administrative stay—something that would have allowed it to continue operating while the case proceeds. Kalshi Confident in Legal Position Kalshi emailed users on Saturday to confirm it would restrict Nevada users from accessing sports, entertainment, and election markets. The email stated, “We’ll get straight to it. Due to a temporary court order, our sports, entertainment, and election-related markets are being restricted in Nevada. You can still sell your positions or wait for them to settle, but you won’t be able to buy new contracts.” It added, “This situation is unprecedented—Nevada is currently the only state with temporary restrictions in place from a court order. We disagree with these restrictions, but as a law-abiding company, we’re complying. We’re confident in our legal stance and will keep fighting for your right to trade the same products available in 49 other states.” Other states have issued unfavorable rulings against Kalshi but generally allowed the company to keep operating until those rulings are finalized. In Massachusetts, a judge granted the state an injunction, but Kalshi won a motion to stay from the appeals court. Latest Lawsuit Names Kalshi Founders As it battles state regulators across the country, Kalshi is also facing a wave of lawsuits from individuals and legal firms. The latest filing specifically names Kalshi co-founders Tarek Mansour and Luana Lopes Lara. The company’s Chief Compliance Officer, Joshua Beardsley, is also named in the suit, which was filed in California. As gaming lawyer Daniel Wallach highlighted, the lawsuit notes the defendants initially “admitted that Sporting Event Contracts have ‘no inherent economic significance.’” During a hearing where Kalshi fought for the legal right to offer election markets, a company lawyer stated, “[Y]ou can see it in the congressional record, and they give three examples of gaming contracts: Football, horse racing, golf. They’re all games. It’s something that has no inherent economic significance. It’s done for amusement. It may be purely to facilitate betting itself for its own sake.” The lawsuit alleges that despite “repeatedly recognizing this legal line in the sand, the Kalshi Defendants got greedy and crossed it in bad faith.” Legal firms from four states filed the lawsuit on Friday. Unlike most litigation—which focuses on the company violating state gambling laws—the suit claims Kalshi is breaking the Commodity Exchange Act (CEA), the rulebook for prediction market platforms. The CEA prohibits gaming-related markets, but the Commodity Futures Trading Commission (CFTC) has not opposed platforms offering sports markets. It has issued an advisory on sports markets but has not gone so far as to say these markets constitute gaming. Despite mounting legal challenges, Kalshi recorded its second-highest single-day trading volume thanks to March Madness and surpassed $3 billion in weekly trading volume. The company was valued at $22 billion in a recent funding round. This article is provided by a third-party. AsiaGameHub (https://asiagamehub.com/) makes no warranties regarding its content. AsiaGameHub delivers targeted distribution for iGaming, Casino, and eSports, connecting 3,000+ premium Asian media outlets and 80,000+ specialized influencers across ASEAN.
Japanese Prosecutors Decline to Indict Baseball Star Hideto Asamura in Illegal Gambling Probe
(AsiaGameHub) - Prosecutors in Japan have announced they will not bring charges against Rakuten Eagles professional baseball player Hideto Asamura and two unidentified team staff members for using online casino platforms. Online casinos are prohibited in Japan, and accessing overseas sites from within the country constitutes a crime. On March 4, police referred 35-year-old infielder Asamura and the team officials to public prosecutors, as reported by Japanese media outlet Sponichi Annex. The three were alleged to have violated gambling laws by “using their smartphones to bet on overseas online casino websites.” However, on March 18, the Sendai District Public Prosecutor’s Office released a statement indicating it would not indict any of the trio. The office noted it had “considered various circumstances” but provided no further details on the matter. The Eagles—officially the Tohoku Rakuten Golden Eagles—are based in Sendai, Miyagi Prefecture. The Rakuten Eagles infielder Hideto Asamura in action in 2019. (Image: Jeffrey Hayes [CC BY 2.0]) Hideto Asamura: No Charges for Baseball Star The recent allegations were a poorly timed setback for the Nippon Professional Baseball Organization (NPB), whose new season kicks off Friday, March 27. Last season’s NPB campaign was overshadowed by a series of gambling-related scandals amid a police crackdown on online casino wagering. At least a dozen players and staff from several top NPB teams faced warnings and fines from police and lower courts. The NPB had hoped to move past the issue ahead of the 2026 season. Earlier this year, it held special gambling awareness sessions for rookie players and training for new umpires. Many players accused in such cases have claimed they were unaware that betting on online casino platforms was illegal in Japan. Teams say they now run their own online casino-focused educational sessions to ensure all staff and players understand the criminal nature of online gambling. Team Issues Apology A Rakuten Eagles representative apologized for the incident, stating, “We are deeply sorry for causing [the public] so much worry and inconvenience.” The official said the franchise would “strongly remind those involved of their responsibilities as members of the baseball community.” “As a team, we will strive to further improve our compliance awareness,” the spokesperson added. “We will continue to fully implement measures to prevent a recurrence.” Japanese baseball is not the only league grappling with gambling-related controversies ahead of the upcoming season. In neighboring South Korea, fans criticized three Lotte Giants players after they were found gambling at a betting den in Taiwan during a preseason training camp. Authorities have handed down lengthy suspensions to all three, meaning they will miss most of the 2026 season. The Korea Baseball Organization season begins March 28. This article is provided by a third-party. AsiaGameHub (https://asiagamehub.com/) makes no warranties regarding its content. AsiaGameHub delivers targeted distribution for iGaming, Casino, and eSports, connecting 3,000+ premium Asian media outlets and 80,000+ specialized influencers across ASEAN.
Wellgistics Health Inc. 簽署價值 1.05 億美元的意向書,以評估收購 Neuritek Therapeutics, Inc. 的可能性;該公司致力於開發治療神經系統及精神疾病的創新療法
坦帕, 2026年3月23日 - (亞太商訊 via SeaPRwire.com) - Wellgistics Health, Inc.(「Wellgistics」或「本公司」)(納斯達克代碼:WGRX)今日宣布,已簽署一份非獨家且不具約束力的意向書(「LOI」),以評估潛在收購專注於神經科學研究的機構Neuritek Therapeutics。若這項擬議的全股票交易得以完成,旨在透過擴展其核心技術驅動的藥品分銷及服務業務周邊能力,強化 Wellgistics 現有的營收型醫療保健平台。透過涵蓋處方藥配送、批發分銷及 AI 驅動的患者用藥解決方案的整合生態系統,Wellgistics 串聯了製造商、醫療服務提供者以及遍布全國的獨立藥房網絡。本公司認為,納入一家以研究為導向的組織,將能強化藥物開發與商業化之間的協同效應,使公司得以更早與製藥合作夥伴建立聯繫、提升產品管線的透明度,並創造額外的營收機會;同時透過更整合且具差異化的平台,提升長期股東價值。本交易仍須待盡職調查完成、最終協議的協商與簽署、各方董事會批准,以及其他慣常的交割條件達成後,方能生效。無法保證雙方將簽訂最終協議,亦無法保證擬議交易將按目前預期的條款完成,甚至可能無法完成。該意向書不具約束力,亦不強制任何一方完成擬議交易。任何潛在交易的範圍、結構及條款仍在評估中,並可能因持續進行的盡職調查及協商而發生重大變更。作為更廣泛成長策略的一部分,本公司亦正積極評估醫療保健及生命科學領域的其他戰略機會。這些機會可能包括收購、合作夥伴關係或其他戰略交易。無法保證任何此類舉措將最終促成交易完成。關於 Wellgistics Health, IncWellgistics Health 是一家快速擴張、以科技為驅動的醫療保健平台,定位於藥品分銷與患者獲藥管道的核心。本公司已建立一個涵蓋批發分銷、處方藥配送及人工智慧驅動的獲取解決方案的整合型高效能生態系統,直接串聯製藥廠商、醫療服務提供者及全國性的獨立藥局網絡。透過整合基礎設施、數據與智能自動化,Wellgistics 正執行一套資本效率高的營運模式,旨在於龐大且分散的醫療保健市場中搶佔顯著市佔率。本公司致力於拓展高毛利收入來源、深化與製造商的戰略合作關係,並在整個平台上推動營運槓桿效應。憑藉獨特的端到端服務方案與嚴謹的執行力,Wellgistics 已做好準備加速成長、提升獲利能見度,並為股東創造超乎預期的長期價值。關於 Neuritek Therapeutics Inc.Neuritek Therapeutics Inc. 開發了一種基於生物機制的次世代療法,旨在治療創傷後壓力症候群(PTSD)的根本成因。Neuritek 首款上市療法為口服活性脂肪酸酰胺水解酶 1 型(FAAH1)抑制劑,該酶負責代謝內源性大麻素(AEA),亦是首個針對 PTSD 機制的治療方案。 該公司由威廉·哈普沃斯(William Hapworth)醫學博士創立,他不僅是臨床研究的先驅,更是一位擁有逾 30 年臨床經驗的執業精神科醫師。欲了解更多資訊,請造訪 www.neuritek.com ,或透過 LinkedIn 加入討論:neuritek-therapeutics-inc前瞻性陳述本新聞稿包含符合《1995年私人證券訴訟改革法案》及其他適用聯邦證券法定義義的前瞻性陳述。這些前瞻性陳述包括但不限於:關於潛在收購 Neuritek Therapeutics, Inc.(「Neuritek」)之陳述,包括任何交易的預期架構、估值、時程及完成可能性;意向書之初步且非約束性性質;任何此類交易可能帶來的戰略、營運及財務效益; 本公司協商並簽訂最終協議之能力;本公司取得任何必要融資之能力;任何被收購業務之整合;以及本公司的整體成長策略與未來表現。前瞻性陳述可透過諸如「可能」、「可能」、「將會」、「應」、「預期」、「預估」、「相信」、「意圖」、「計劃」、「預測」、「估計」、「潛在」、 「機會」、「目標」、「預測」、「持續」、「將」及類似表述。此等前瞻性陳述係基於當前預期、假設及估計,並受重大風險與不確定性影響,其中許多因素超出本公司控制範圍。可能導致實際結果與預期存在重大差異的重要因素包括但不限於:各方未能簽訂最終協議的風險;意向書被終止或未能促成交易完成的風險;擬議估值及交易條款具初步性質所帶來的不確定性(此等內容可能發生重大變更);未能以可接受條款取得所需融資或完全無法取得融資的風險; 任何交易預期效益未能實現的風險;將以研究為導向的組織整合至本公司現有業務所伴隨的風險;藥品或治療產品的開發、測試、監管批准及商業化相關風險,包括可能出現不利的臨床結果或延誤;監管及合規風險;以及本公司不時向美國證券交易委員會提交的文件中所述的其他風險與不確定性。前瞻性陳述僅反映其作出當日的狀況,不應過度依賴此類陳述。除適用法律要求外,本公司無義務更新或修訂任何前瞻性陳述。Wellgistics 媒體與投資者聯絡資訊媒體: media@wellgisticshealth.com 投資者關係: IR@wellgisticshealth.com 消息來源:Wellgistics Health, Inc. Copyright 2026 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com
億勝生物科技2025全年業績穩健 收入升8.6%至18.14億港元 淨利潤升3.5%至3.18億港元 全年股息增加16.7%至每股14港仙
關鍵業績摘要:- 收入增長:收入同比增長8.6%至約18.14億港元- 淨利潤提升:得益於運營效率,淨利潤增長3.5%至3.18億港元- 末期股息:擬派末期股息每股0.07港元,2025年全年股息達每股0.14港元,較2024年全年股息的每股0.12港元大幅增加16.7%- 現金及現金等價物:7.83億港元(2024年12月31日:5.57億港元)研發里程碑:- NMPA批准:多劑量地誇磷索鈉滴眼液於2025年7月獲批;多劑量玻璃酸鈉滴眼液於2026年1月獲批在中國註冊和商業化。- BLA受理:貝伐珠單抗眼內注射液的生物製品許可申請(BLA)於2025年8月獲NMPA受理,標誌著重要的監管里程碑。商業發展:- 獨家代理(視方極):獲得浙江視方極富馬酸依美斯汀滴眼液、鹽酸奧布卡因滴眼液的獨家代理權。- 獨家代理(Osteopore):獲得Osteopore創新的牙科、正畸及頜面產品在中國內地、香港及澳門的獨家代理權。- 與鷹瞳科技合作:在中國實現眼底AI業務的聯合運營。- 與科赴戰略合作:在中國推廣及營銷科赴的消費者健康產品(雷諾考特(R)、美林(R)、泰諾林(R))。- 國際創新加速器:與蘇州工業園區簽訂戰略合作諒解備忘錄,推出國際創新加速器。- 首個海外市場准入:貝復舒(R)通過特別採用程序成功引入新加坡國家眼科中心。知識產權與市場佈局:- 強大的知識產權組合:持有合共121份專利證書或授權書,包括91項發明專利、15項實用新型專利及15項外觀專利。- 廣泛的銷售網絡:產品覆蓋中國內地超14,600家醫院和醫療機構以及約2,600家藥房。獎項與榮譽:- 2025年廣東省製造業企業500強:表彰產業規模及綜合競爭力- 國家級製造業單項冠軍企業:確認在專業生物製藥領域的領先地位- 2025「金鯤鵬」中國財經價值榜-最具投資價值上市公司:突顯資本市場對增長潛力的認可- 參與2026年亞太眼科學會大會:展示主要眼科產品及在研管線,加強與區域眼科專業人士及機構的聯繫。香港, 2026年3月23日 - (亞太商訊 via SeaPRwire.com) - 億勝生物科技有限公司(「億勝生物」及其附屬公司「集團」;股份代號:1061.HK),一家領先的生物製藥企業,專注於研發、生產和銷售基因工程藥物重組牛鹼性成纖維細胞生長因子(「rb-bFGF」),今日公佈截至2025年12月31日止的強勁年度業績。集團收入同比增長8.6%至18.14億港元,利潤同比增長3.5%至3.18億港元。年內,億勝生物達成了多項監管里程碑,並通過戰略合作擴大了產品組合,同時成功將貝復舒(R)引入新加坡。這些成就彰顯了億勝對創新和卓越運營的承諾,持續推動收入和利潤的增長勢頭。旗艦生物藥推動多元化增長集團實現綜合營業額約18.14億港元,較2024年的約16.70億港元增長8.6%。相應地,集團溢利較2024年的約3.07億港元增長3.5%至約3.18億港元。集團的旗艦產品貝復舒(R)系列及貝復濟(R)系列持續帶動增長,佔總營業額的83.5%。眼科分部錄得營業額8.35億港元,同比大幅增長8.2%。其中,單劑量貝復舒(R)滴眼液憑藉無防腐劑設計及應用場景的持續拓展(覆蓋乾眼症治療及術後修復等多元領域)實現強勁銷售增長,貝復舒(R)眼用凝膠、適麗順(R)(卵磷脂絡合碘膠囊)和一系列不含防腐劑單劑量滴眼液(包括妥布黴素、左氧氟沙星、玻璃酸鈉、鹽酸莫西沙星及地誇磷索鈉滴眼液)亦作出持續貢獻。外科分部實現營業額8.96億港元,增長1.8%,主要受惠於貝復濟(R)系列產品在多個臨床科室的廣泛應用及其穩固的市場地位。同時,貝復濟(R)系列產品已獲多項臨床指南及專家共識支持,為未來適應症拓展及持續增長奠定基礎。此外,集團的Carisolv(R)齲齒凝膠、皮耐克可吸收性敷料、適可健雙層人工真皮修復材料等產品進一步增強並促進了外科業務的發展。值得注意的是,醫療保健及夥伴服務於截至2025年12月31日止年度錄得總營業額約8,290萬港元,較2024年大幅增長350%。增長主要來源於伢典醫生口腔護理產品、線上及線下醫療保健服務及CMO/CDMO服務等。穩健的財務基礎和股東回報集團維持穩健的財務狀況。截至2025年12月31日,集團錄得現金及現金等價物約7.83億港元。銀行借貸為3.26億港元,將在未來五年內按計劃償還。集團的資產負債比率為30.9%(2024年:28.8%),反映出集團具備嚴謹的財務管理能力和充足的流動性。董事會欣然建議派發末期股息每股普通股0.07港元。連同中期股息每股普通股0.07港元,2025年全年股息達到0.14港元,較2024年全年股息的0.12港元同比顯著增長16.7%,以彰顯集團致力於為股東創造價值的承諾。廣泛的產品組合及強大的研發管線支持持續增長集團業務由三個核心分部組成:眼科、外科(創傷護理及修復)以及醫療保健及夥伴服務分部。集團擁有六種於中國市場銷售的商業化生物製劑,統稱「bFGF系列」。其中三種bFGF系列為國家藥品監督管理局(「NMPA」)批准的國家一類新藥,五種被列入中國國家基本醫療保險、工傷保險和生育保險藥品目錄。此外,集團提供一系列商業化的不含防腐劑單劑量滴眼液,包括妥布黴素、左氧氟沙星、玻璃酸鈉、鹽酸莫西沙星及地誇磷索鈉滴眼液。集團進一步拓展其眼科產品組合,分別於2025年7月及2026年1月獲得NMPA批准多劑量地誇磷索鈉滴眼液及多劑量玻璃酸鈉滴眼液在中國註冊和商業化。新獲批產品聚焦於中國不斷增長的幹眼治療市場,以補充集團的貝復舒(R)眼表修復系列產品。外科方面,集團的Carisolv(R)齲齒凝膠及伢典醫生口腔護理產品,以及一系列產品及醫療器械(包括紫外線光療儀、皮耐克可吸收性敷料、Osteopore用於牙科手術的生物可吸收植入物(Osteomesh(R)及Osteoplug(R))及其他用於近視防控的醫療器械),共同補充了集團的貝復濟(R)創傷修復系列產品。戰略性研發投資以把握新興市場機遇集團致力於務實地投資新產品及技術,以強化其產品及研發管線,使命是開發解決未滿足的臨床及商業需求的突破性的療法。2025年,研發總支出約為1.77億港元,佔營業額的9.8%,其中約1.39億港元已資本化。年內,集團醫用疤痕修復凝膠獲批NMPA二類醫療器械註冊證,將集團業務拓展至快速增長的高端傷口護理及醫療美容市場,解鎖新增長動力以推動長期發展。貝伐珠單抗眼內注射液(EB12-20145P)的全球三期臨床項目已成功完成了在中國、澳大利亞、歐盟國家及美國的患者入組,最後一名患者已完成最後一次訪視。其生物製品許可申請(BLA)已於2025年8月獲中國NMPA受理。為提升集團在亞洲眼科領域的影響力,並加速新產品的市場推出,集團參與了2026年亞太眼科學會(APAO)大會。該會議提供了一個絕佳平台,用以展示眼科解決方案、與區域臨床專家和合作夥伴交流,並為集團創新眼科產品的推出積聚動能,從而提升全球品牌影響力。集團持有121份專利證書或授權書,包括91項發明專利、15項實用新型專利及15項外觀專利。集團目前於珠海(中國)、波士頓(美國)、倫敦(英國)及新加坡設立多個研發基地。這些基地為集團開發新療法和招募全球人才提供支援。截至目前,集團共有18項研發計劃處於臨床前至臨床階段,其中數項眼科項目處於臨床階段,具體包括貝伐珠單抗眼內注射液、SkQ1滴眼液及環孢素滴眼液。透過市場擴張與合作拓寬商業覆蓋截至2025年12月31日,集團於中國設有47間地區銷售辦事處,並於新加坡設有戰略基地,以促進其產品進入東南亞市場。憑藉龐大的分銷網絡,集團的治療產品在中國各地的逾14,600家醫院及醫療機構以及約2,600家藥房開具處方,覆蓋了中國各地的主要城市。回顧年內,集團在國內外市場擴張方面取得了多項里程碑式的突破,解鎖了多維度的新增長動力。在海外市場,集團的旗艦產品貝復舒(R)通過特別採用程序成功引入新加坡國家眼科中心,標誌著該產品首次進入中國以外地區,為集團未來進軍東南亞及全球市場奠定了堅實基礎。在國內,集團年內達成了兩項具里程碑意義的戰略合作:與全球消費者健康領導企業科赴合作,利用集團在中國廣泛的全國性商業網絡,對科赴精選的消費者健康產品(包括雷諾考特(R)、美林(R)及泰諾林(R))進行推廣、學術教育及營銷;以及與Osteopore簽訂獨家分銷協議,在中國內地、香港及澳門分銷其創新的牙科、正畸及頜面產品,標誌著集團戰略性進軍高潛力的口腔科市場。這些合作拓寬了集團醫療保健業務的版圖,並與其現有的眼科及再生醫學業務產生強大的協同效應。為推動現有及未來產品的可持續增長和擴張,集團一直不懈地進行投資,通過擴大其商業化產品的臨床適應症、增加中國較低線城市的患者可及性、開發補充銷售渠道,以及培育醫療科技電子平台以增強患者可及性,來提高其競爭力並拓寬覆蓋範圍。集團位於珠海高新區科技創新海岸的第二間工廠,建築面積約58,000平方米,用作研發、生產、辦公及宿舍,預計將於2026或2027年間完工。億勝生物主席嚴名熾先生表示:「2025年對億勝來說是具有里程碑意義的一年,貝復舒(R)成功引入新加坡,集團亦依託其核心產品、創新研發及戰略合作,實現穩健增長。未來,億勝將繼續致力於滿足未被滿足的臨床需求,推動集團長期發展。我们將主動、系統性地優化運營及銷售成本,以缓解增值税由3%上调至13%对2026财年利润带来的不利影响,同时保證集團發展規劃的穩步推進。」關於億勝生物(股票代碼﹕1061.hk)億勝生物是一間專注於研發、生產和銷售基因工程藥物b-bFGF的生物製藥企業,擁有包括貝復舒(R)、貝復濟(R)、貝復新(R)在內的六種基因工程藥物在中國上市銷售。此外,公司還擁有包含一系列不含防腐劑單劑量滴眼液和適麗順(R)卵磷脂絡合碘膠囊等的多元化產品組合,主要應用於眼科及皮膚科處方藥領域的創傷修復及疾病治療。這些產品在公司於中國的47個區域辦事處的支持下,在逾14,600家醫院進行營銷和銷售。依託自身在生長因子和抗體技術領域的研發平台,億勝生物在多個臨床階段擁有强大的項目管線,涵蓋廣泛的領域和適應症。網址: http://www.essexbio.com Copyright 2026 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com
Analysts Predict Surge in Casino Mergers and Acquisitions
(AsiaGameHub) - Analysts anticipate a surge in casino acquisition and merger activity, following reports that Caesars is considering a takeover bid. A Period of Strong M&A Activity Might Be on the Horizon Caesars is reportedly contemplating selling its business, with Tilman Fertitta and Carl Icahn identified as potential acquirers. In light of this, Barry Jones, Managing Director at Truist Securities, and John DeCree, Director of Equity Research at CBRE, have projected an increase in M&A activity across the broader casino sector. As reported by CDC Gaming, DeCree highlighted that the rumored Caesars takeover remains highly speculative. He noted that individuals familiar with the situation believe that if a deal were to materialize, the existing Caesars leadership would likely remain in place, resulting in minimal operational changes for the company. Jonas commented that a potential Caesars takeover could trigger a period of heightened M&A activity, as other company boards might be motivated to explore similar takeover offers. DeCree concurred that the gaming sector could experience increased M&A, expressing optimism about a Caesars deal due to the company's diverse portfolio and the current "near record lows" in interest rates and spreads for large corporations. Going Private and Investing Abroad Are Viable Options Jonas suggested that some operators might opt to go private, prioritizing long-term success over short-term investor demands. He added that if stock valuations remain stable, more private transactions could occur, noting that many B2B companies in the gaming sector have already transitioned to private ownership. DeCree pointed out that acquisitions of The Mirage and Venetian were made by private entities, but emphasized that such transactions require substantial capital. He also noted that companies with significant capital often find targeting Las Vegas challenging, leading them to focus on emerging markets, citing MGM Osaka and Wynn Al Marjan as prominent examples. Las Vegas Remains of Key Importance Jonas stated that most casino companies would desire a presence in Las Vegas, though the extent of property ownership remains a key consideration. DeCree referenced Hard Rock's redevelopment of The Mirage, which involved a multi-year closure, as a significant recent development. However, Jonas characterized Hard Rock as an "unconventional buyer" and suggested that while redeveloping lower-tier Vegas properties is logical, it requires specific types of buyers. Furthermore, Jonas noted that not all Las Vegas investments yield immediate strong returns, citing the challenges faced by Fontainebleau and Resorts World in achieving their projected performance. Despite any slowdown on the Las Vegas Strip, Jonas indicated that the local market has not been significantly impacted, suggesting that investments in the city remain viable. This article is provided by a third-party. AsiaGameHub (https://asiagamehub.com/) makes no warranties regarding its content. AsiaGameHub delivers targeted distribution for iGaming, Casino, and eSports, connecting 3,000+ premium Asian media outlets and 80,000+ specialized influencers across ASEAN.
Jake Paul Announces Betr Online Casino Now Operating in 30 States
(AsiaGameHub) - Betr, the online social casino platform, has now launched fully across 30 states in the United States amid increasing industry oversight, marking the company's latest product offering. The brand's co-founder and primary promoter, Jake Paul, a YouTuber turned boxer, has been actively marketing the platform and recently verified the announcement via a post on social media platform X. The massive days just keep coming for @betr We just launched the Betr Social Casino in 30+ states https://t.co/eUBwoGgMPB— Jake Paul (@jakepaul) March 17, 2026 The Betr brand has experienced rapid growth and has diversified into multiple verticals over time. The casino product represents the latest addition to its portfolio, joining existing offerings such as Betr Arcade, Betr Social Sportsbook, and Betr Picks. The company appears poised for further expansion, taking inspiration from DraftKings' approach, as Jake Paul has hinted at the development of a super app that would consolidate all products under one umbrella and potentially incorporate prediction markets in the near future. "We've definitely established a first-mover advantage with our super-app approach. Through our social casino, we'll maintain an edge by offering a casino-style product available nationwide. Modern consumers don't want to download five to seven separate apps with different wallets—it's simply too cumbersome," Jake Paul stated during his attendance at the Next Summit: New York, according to media reports. Both social online casinos and prediction markets are encountering significant regulatory and operational hurdles. Minnesota is currently advocating for prohibition of social casinos, with particular focus on the sweepstakes model. Indiana has likewise enacted legislation that outlaws the sweepstakes model. Prediction markets are also experiencing resistance, as evidenced by a recent ruling in Nevada that resulted in the temporary halt of Kalshi products in that state. Although regulators appear to favor supporting the prediction market sector, advocacy groups like Gambling Is Not Investing and proposed legislation such as the Bets Off Act are highlighting the growing resistance to the industry. This represents just one of multiple legislative initiatives targeting the sector. This article is provided by a third-party. AsiaGameHub (https://asiagamehub.com/) makes no warranties regarding its content. AsiaGameHub delivers targeted distribution for iGaming, Casino, and eSports, connecting 3,000+ premium Asian media outlets and 80,000+ specialized influencers across ASEAN.
NCAA Demands DraftKings Halt March Madness Branding
(AsiaGameHub) - On Friday, March 20, the National Collegiate Athletic Association (NCAA) submitted a formal complaint to a federal court, requesting that DraftKings cease using the “March Madness” branding. The filing contends that the sportsbook should discontinue its use of registered trademarks associated with the NCAA’s men’s and women’s basketball tournaments. NCAA Says DraftKings Uses Its Trademarked Brands The NCAA has identified specific names and branding that DraftKings must avoid, seeking legal prohibition of their use. These include “March Madness,” “Final Four,” “ Elite Eight,” and “Sweet Sixteen,” which refer to different stages of the competition that generates massive overall gambling revenue. The complaint further stipulates that these terms should be prohibited from appearing in the company’s sports betting offerings, promotional activities, or marketing materials. The NCAA elaborated on the matter in its filing: “Just before the Tournaments began, DraftKings intentionally embraced and prominently deployed the NCAA’s iconic basketball trademarks, along with deceptively similar variants, to exploit and appropriate the considerable goodwill, recognition, and consumer confidence those Marks represent at the exact time of maximum public interest.” The NCAA contended that DraftKings lacked any legitimate authority to integrate the tournament branding and imagery into its public-facing websites and applications, thereby “intentionally intensifying consumer confusion and cementing a misleading connection or sponsorship affiliation with the NCAA to persistently profit from the Association’s established reputation.” DraftKings has challenged the complaint and its particular structure, asserting that the company never meant to employ – nor actually utilized – the “March Madness” branding, but instead applied it as “plain text” and as a “ fair use,” making comparisons to how other competitions are presented. DraftKings Objects, Says Fair Use “This constitutes protected speech under the First Amendment and does not infringe upon any brand’s trademark. We are confident the courts will reject this injunction request,” the company maintained. The NCAA has demanded that this usage cease, as it subjects millions of vulnerable sports enthusiasts and, importantly, college students and young adults to the risks of gambling. “[They are] exposed to the false suggestion that the Association has authorized or endorsed DraftKings’ gambling platform,” the NCAA concluded.The NCAA has been seeking to protect athletes from betting-related abuse and minimize opportunities for match-fixing by urging gambling industry stakeholders to prohibit proposition betting on college-level games. This article is provided by a third-party. AsiaGameHub (https://asiagamehub.com/) makes no warranties regarding its content. AsiaGameHub delivers targeted distribution for iGaming, Casino, and eSports, connecting 3,000+ premium Asian media outlets and 80,000+ specialized influencers across ASEAN.
雲頂新耀達成艾曲帕米鼻噴霧劑資產收購協議 強化心血管領域產品佈局
香港, 2026年3月23日 - (亞太商訊 via SeaPRwire.com) - 雲頂新耀宣佈與箕星藥業香港有限公司(以下簡稱「箕星藥業」)達成資產收購協議 (The Asset Purchase Agreement),獲得艾曲帕米(Etripamil)鼻噴霧劑(擬定中文商品名:星必妥(R))在大中華區的開發、商業化及產品地產化權益。此次合作是公司深化心血管領域戰略佈局的重要舉措,進一步豐富了公司的產品管線、增強協同效應,持續鞏固公司在心血管疾病領域的發展。根據協議,雲頂新耀將向箕星藥業支付3000萬美元(相當於約人民幣206,937,000元)首付款,以及最高不超過2000萬美元(相當於約人民幣137,958,000元)的開發裏程碑付款。作為本協議的一部分,雲頂新耀將獲得箕星藥業於2021年5月簽訂的許可協議及相關附屬協議項下的權利、權益、主張、職責、義務及責任(不包括雙方約定的部分除外責任)。艾曲帕米鼻噴霧劑是一款新型、速效的鈣離子通道阻滯劑,采用便攜式鼻噴霧劑給藥,起效迅速且耐受性良好,可居家自行使用,可及性高。該藥物於2025年12月獲得美國食品藥品監督管理局(FDA)批准(美國商品名:CARDAMYSTTM),成為30多年來首款且唯一獲批用於成人陣發性室上性心動過速(PSVT)急性症狀性發作的療法,開拓了PSVT治療新場景。患者可在無醫療監督的環境(如居家)自行給藥,實現對病情的主動掌控,使疾病管理從依賴急診幹預轉向更加主動的院外管理。此外,艾曲帕米鼻噴霧劑正開發用於伴有快速心室率反應的房顫(AFib-RVR)適應症,II期臨床研究已取得積極結果,並計劃推進III期臨床研究,未來有望進一步拓展至更廣泛患者人群。在中國,艾曲帕米鼻噴霧劑用於治療PSVT的新藥上市申請已於2025年1月17日獲中國國家藥品監督管理局(NMPA)正式受理,並預計於2026年第三季度獲批,有望為PSVT患者提供全新的治療選擇。PSVT是一種以突發突止為主要特征的心動過速臨床綜合征,發作時心率極快且節律規則,通常持續數分鐘至數小時,患者症狀明顯且恐懼感強。PSVT急性發作的治療缺乏安全、便捷、可在院外自行使用的快速終止藥物,使患者在發作期長期處於「被動等待」狀態,缺乏真正意義上的「按需自救」工具。據悉,在中國,每1000中約有2.3-4人患有PSVT,估計總患者人數為300-600萬。AFib-RVR的特征是心率不規則,紊亂且快速,呈漸進式發作且不易自行終止,容易反複持續。目前中國的房顫患病率1.6%,對應患者人數約2000萬,並隨老齡化加劇呈上升趨勢。PSVT與AFib-RVR都會增加患者的失控感和心理負擔。整體來看,PSVT及AFib-RVR患者人群規模超過2500萬人,臨床需求遠未得到滿足,亟需更便捷、更高效的治療選擇。臨床數據方面,此次艾曲帕米鼻噴霧劑獲中國NMPA新藥上市申請受理是基於艾曲帕米關鍵性III期 RAPID 研究和中國III期 JX02002 臨床研究所取得的數據結果。JX02002研究達到了方案預設的主要終點,治療期出現的不良事件(TEAEs)在艾曲帕米治療組和安慰劑組之間相當。艾曲帕米鼻噴霧劑獲FDA批准是基於一項紮實的臨床試驗項目所得出的結論,該項目共收集了來自超1,800名參與者、超2,000次PSVT發作的安全性數據。這包括成功的3期RAPID試驗,這是一項在全球範圍內開展的、隨機、雙盲、安慰劑對照研究,結果於2023年發表在《柳葉刀》雜志上。RAPID試驗達到了其主要終點:自行使用艾曲帕米的參與者(N=99)中有64%在30分鐘內從室上性心動過速轉為竇性心律,而安慰劑組(N=85)為31%(HR = 2.62; p<0.001),中位轉複時間為17分鐘(95% CI:13.4,26.5),而安慰劑組為54分鐘(95% CI:38.7,87.3)。 艾曲帕米鼻噴霧劑正開發用於AFib-RVR適應症。在國際多中心、隨機、安慰劑對照的II期 ReVeRA 研究中,艾曲帕米顯著且快速地降低了AFibRVR患者的心室率,達到了主要終點。接受艾曲帕米治療的患者中,心室率低於100 bpm的人數(58.3%)高於接受安慰劑治療的人數(4%)。安全性總體良好並與既往研究結果一致。從戰略層面看,此次交易亦被視為雲頂新耀落實「2030戰略」的重要一步。在 2030 戰略的指引下,公司通過聚焦「BD合作+自研」雙輪驅動模式加速發展,全面推進戰略性業務拓展與自主研發,不斷豐富管線與產品組合,推進全球研發體系建設,並依托成熟的商業化實力,持續提升在全球創新藥領域的綜合競爭力,為患者提供創新療法並創造長期可持續價值。雲頂新耀董事會主席吳以芳先生指出,此次與箕星藥業的合作標志著公司在心血管領域戰略佈局的重要進展,體現了雲頂新耀對戰略落地的持續踐行與承諾,並通過進一步完善產品組合、強化核心戰略能力,展示公司在戰略規劃與執行上的前瞻視野,彰顯雲頂新耀在全球創新藥領域的領先發展格局。雲頂新耀首席執行官羅永慶表示:「此次與箕星藥業達成艾曲帕米鼻噴霧劑的資產收購協議,是公司深耕心血管領域的關鍵一步,也是推進2030戰略過程中取得的重要進展。艾曲帕米鼻噴霧劑是目前唯一可居家自行用於PSVT以及AFib-RVR急性發作的藥物,中國患者存在巨大的未滿足臨床需求。未來,雲頂新耀將依托成熟的臨床開發能力與卓越的商業化平台,加快艾曲帕米鼻噴霧劑在中國的注冊與商業化,助力更多患者受益,並充分發揮其長期臨床與商業價值。」隨著艾曲帕米鼻噴霧劑在中國注冊及商業化進程的推進,公司有望進一步拓展在心血管領域的產品佈局。未來,雲頂新耀將依托成熟的臨床開發體系與商業化平台,加快創新資產的落地與價值釋放,持續推進2030戰略實施,為患者帶來更多創新治療選擇。 Copyright 2026 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com
VALYGO Launches Integrated Platform Bridging Crypto, Fiat, and Global Payments
BASSETERRE, KN – 10/03/2026 – (SeaPRwire) – As digital assets, traditional banking services, and global payment networks continue to evolve independently, individuals and businesses that operate internationally often face a fragmented financial landscape. Addressing this challenge, the VALYGO platform has officially launched, introducing a unified financial environment designed to consolidate multiple financial functions into a single operational framework. Modern financial activity frequently requires users to rely on separate systems for cryptocurrency management, fiat transactions, payment processing, and cross-border transfers. This fragmentation can slow financial operations, create administrative complexity, and increase operational friction for professionals and companies conducting business across multiple jurisdictions. VALYGO enters this space with the goal of simplifying financial workflows by bringing these capabilities together within one structured platform. A Platform Designed Around Real Financial Workflows Rather than focusing on a single financial service, VALYGO has been designed around the way individuals and businesses interact with money in real-world scenarios. The platform enables users to operate within a connected account environment where several financial functions can coexist and interact. Through the platform, users are able to manage digital assets alongside supported fiat services, conduct card-based transactions both online and at physical merchants, and execute cross-border transfers without relying on multiple external systems. In addition, supported ATM access provides another method for interacting with funds. By integrating these services into one platform environment, VALYGO aims to reduce the need for users to shift between different tools and platforms, helping create greater continuity in everyday financial activity. Supporting Cross-Border Financial Participants The platform has been developed with internationally active users in mind. Freelancers who invoice clients abroad, remote professionals earning income from multiple regions, and businesses maintaining relationships with clients across different countries often require financial infrastructure capable of supporting complex payment flows. VALYGO’s structure seeks to address these needs by providing an operational environment where payments, asset management, and account access can function within a single system. Individuals who frequently interact with both cryptocurrency and traditional financial services may also find value in the platform’s integrated structure. Flexible Account Models for Different Operational Needs Recognizing that users operate at varying scales, VALYGO offers multiple account tiers designed to accommodate different levels of financial activity. This structured approach allows participants to select an account model aligned with their operational requirements. Entry-level access is available for users with more basic needs, while higher-tier accounts provide expanded functionality and may involve participation through the VYO ecosystem component. By offering tiered access, the platform seeks to provide scalability without imposing identical requirements on all participants. VYO Utility Within the Platform Ecosystem Within the VALYGO ecosystem, VYO functions as a utility component connected to platform participation. Its use cases include enabling access to certain account tiers, supporting staking participation, and linking token utility with platform functionality. Rather than existing independently from the platform environment, VYO is designed to operate as part of the broader ecosystem infrastructure, aligning user participation with the system’s operational structure. Transitioning from Development to Active Use With the platform now live, users are able to engage with VALYGO under real operating conditions. The launch represents the transition from development and system design to practical usage. While future updates and improvements may continue as the platform evolves, the current release establishes the foundation for users to interact with a financial environment that brings together digital assets, payment tools, and supported fiat services within a single operational framework. A Unified Operational Layer for Modern Finance VALYGO does not position itself as a traditional bank replacement, a trading platform, or solely a cryptocurrency wallet. Instead, it presents itself as an integrated operational layer intended to connect several financial functions—ranging from crypto access and supported fiat services to payment infrastructure and account management—within one unified environment.











